{"id":765026,"date":"2023-06-21T08:13:05","date_gmt":"2023-06-21T12:13:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/"},"modified":"2023-06-21T08:13:05","modified_gmt":"2023-06-21T12:13:05","slug":"ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/","title":{"rendered":"Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts"},"content":{"rendered":"

\nThe company is one of the first in the U.S. with complete end-to-end gene therapy capabilities in Massachusetts, from research and development to therapeutic production at scale
\n<\/h2>\n
\n

BEDFORD, Mass., June 21, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc.<\/a>, a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today officially opened its gene therapy manufacturing facility in Bedford, Massachusetts. The company has a large and diverse clinical pipeline of late-stage gene therapies for the potential treatment of rare genetic conditions. This new, state-of-the-art facility will enable Ultragenyx to produce gene therapy treatments reliably and at scale, leveraging the company\u2019s proprietary Pinnacle PCLTM<\/sup> (producer cell line) manufacturing platform. Pinnacle PCL enables greater efficiency in producing adeno-associated virus (AAV) gene therapies with improved product quality and yield, lower cost and increased speed of production.<\/p>\n

\u201cToday we\u2019re celebrating the result of several years\u2019 worth of effort by hundreds of people, all driven by a single shared goal \u2013 to transform the lives of people living with rare disease,\u201d said Dennis Huang, chief technical operations officer and executive vice president for gene therapy research and development at Ultragenyx. \u201cThrough this facility, Ultragenyx will develop and produce gene therapy treatments at greater scale than previously possible, which we believe will make these rare disease medicines more accessible to the people who need them.\u201d<\/p>\n

Ultragenyx recently finished construction of the 110,000-square-foot gene therapy manufacturing facility on a 10.7-acre site in Bedford, which was selected due to its proximity to Ultragenyx\u2019s research and development operations in the Greater Boston area. The company plans to hire 120 employees to staff the facility from a range of skill levels and backgrounds. Ultragenyx currently employs more than 350 people in Massachusetts across its sites in Bedford, Woburn and Cambridge \u2013 more than a quarter of its global workforce.<\/p>\n

The company worked closely with the Town of Bedford and various community partners in the region, starting with site selection and groundbreaking and continuing through construction and activation. Throughout the process, Ultragenyx developed close working partnerships with the Town of Bedford, local educational institutions including Middlesex Community College, leading life science organizations such as Massachusetts Biotechnology Council (MassBio) and Massachusetts Life Sciences Center and organizations including the Bedford and Woburn Chambers of Commerce and Middlesex 3 Coalition, among others. Ultragenyx is committed to continued collaboration with these local and regional partners moving forward.<\/p>\n

Ultragenyx will hold a Grand Opening ceremony to celebrate with all its Massachusetts-based employees and invited guests on Wednesday, June 21 from 1:00pm to 2:00pm EDT. The event will include remarks from Ultragenyx leaders, local elected officials and rare disease patient advocates.<\/p>\n

\n About Ultragenyx <\/strong>
\n
Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultrarare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx\u2019s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.<\/p>\n

For more information on Ultragenyx, please visit the company’s website at: www.ultragenyx.com<\/a>.<\/p>\n

A photo accompanying this announcement is available at https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/7059e879-4e18-468b-880e-886b2923ff24<\/a><\/p>\n

\n Contacts:<\/strong>\n <\/p>\n

Investors
Joshua Higa
ir@ultragenyx.com<\/a><\/p>\n

Media
Jeff Blake
415-612-7784
media@ultragenyx.com<\/a><\/p>\n

\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

The company is one of the first in the U.S. with complete end-to-end gene therapy capabilities in Massachusetts, from research and development to therapeutic production at scale BEDFORD, Mass., June 21, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today officially opened its gene therapy manufacturing facility in Bedford, Massachusetts. The company has a large and diverse clinical pipeline of late-stage gene therapies for the potential treatment of rare genetic conditions. This new, state-of-the-art facility will enable Ultragenyx to produce gene therapy treatments reliably and at scale, leveraging the company\u2019s proprietary Pinnacle PCLTM (producer cell line) manufacturing platform. Pinnacle PCL enables greater efficiency in … <\/p>\n

Continue reading “Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-765026","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nUltragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"The company is one of the first in the U.S. with complete end-to-end gene therapy capabilities in Massachusetts, from research and development to therapeutic production at scale BEDFORD, Mass., June 21, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today officially opened its gene therapy manufacturing facility in Bedford, Massachusetts. The company has a large and diverse clinical pipeline of late-stage gene therapies for the potential treatment of rare genetic conditions. This new, state-of-the-art facility will enable Ultragenyx to produce gene therapy treatments reliably and at scale, leveraging the company\u2019s proprietary Pinnacle PCLTM (producer cell line) manufacturing platform. Pinnacle PCL enables greater efficiency in … Continue reading "Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-21T12:13:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MTY4OCM1NjU3MDI3IzIwMDkyOTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts\",\"datePublished\":\"2023-06-21T12:13:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/\"},\"wordCount\":606,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2MTY4OCM1NjU3MDI3IzIwMDkyOTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/\",\"name\":\"Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2MTY4OCM1NjU3MDI3IzIwMDkyOTE=\",\"datePublished\":\"2023-06-21T12:13:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2MTY4OCM1NjU3MDI3IzIwMDkyOTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2MTY4OCM1NjU3MDI3IzIwMDkyOTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/","og_locale":"en_US","og_type":"article","og_title":"Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts - Market Newsdesk","og_description":"The company is one of the first in the U.S. with complete end-to-end gene therapy capabilities in Massachusetts, from research and development to therapeutic production at scale BEDFORD, Mass., June 21, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today officially opened its gene therapy manufacturing facility in Bedford, Massachusetts. The company has a large and diverse clinical pipeline of late-stage gene therapies for the potential treatment of rare genetic conditions. This new, state-of-the-art facility will enable Ultragenyx to produce gene therapy treatments reliably and at scale, leveraging the company\u2019s proprietary Pinnacle PCLTM (producer cell line) manufacturing platform. Pinnacle PCL enables greater efficiency in … Continue reading \"Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/","og_site_name":"Market Newsdesk","article_published_time":"2023-06-21T12:13:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MTY4OCM1NjU3MDI3IzIwMDkyOTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts","datePublished":"2023-06-21T12:13:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/"},"wordCount":606,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MTY4OCM1NjU3MDI3IzIwMDkyOTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/","name":"Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MTY4OCM1NjU3MDI3IzIwMDkyOTE=","datePublished":"2023-06-21T12:13:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MTY4OCM1NjU3MDI3IzIwMDkyOTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MTY4OCM1NjU3MDI3IzIwMDkyOTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-opens-new-gene-therapy-manufacturing-facility-in-bedford-continuing-its-expansion-in-massachusetts\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/765026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=765026"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/765026\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=765026"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=765026"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=765026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}